Correspondingly, co-inhibition of Notch1 in P-MSCs reversed the effects of IGF2BP2 knockdown on MSCs reprogramming (Fig. 6A–D), as well as the effects of their supernatants on gastric cancer cell proliferation, migration, and drug resistance (Fig. 6E–H). This evidence concerns the gene IGF2BP2 and gastric cancer.